Form 4/A for IMDX Insight Molecular Diagnostics Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-10-31 · accession 0001493152-25-022358 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-11-13 | 2025-10-31 | IMDX | James Andrea S. | CFO | F - Tax | $6.01 | -12.2K | 189.1K | -6% | -$73.2K |
| DA | 2025-11-13 | 2025-10-31 | IMDX | James Andrea S. | CFO | M - OptEx | $0.00 | +50.0K | 201.2K | +33% | $0 |
| DA | 2025-11-13 | 2025-10-31 | IMDX | James Andrea S. | CFO | M - OptEx | $0.00 | -50.0K | 50.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | F | D | 12,175 | $6.01 | 189,056 | D | — | — | (F2) The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares. |
| 2 | Common | Common Stock | 2025-10-31 | M | A | 50,000 | $0.00 | 201,231 | D | — | — | (F1) Represents vesting an award of performance-based restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. |
| 3 | Derivative | Restricted Stock Units | 2025-10-31 | M | D | 50,000 | $0.00 | 50,000 | D | — · — to — | 50,000 Common Stock | (F1) Represents vesting an award of performance-based restricted stock units ("RSUs") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. (F3) The RSUs vested on the last day of the month upon satisfaction of the "Baby Shelf" performance condition described in the Reporting Person's Employment Agreement, which required that the Company's public float reach at least $75 million such that the Company would no longer be subject to the SEC's "baby shelf" limitations on Form S-3 eligibility. The satisfaction of this condition resulted in the vesting of 50% of the RSUs granted to the Reporting Person, subject to the Reporting Person's continued service. |